.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
Colorcon
Baxter
Express Scripts
Fish and Richardson
Cantor Fitzgerald
McKesson
Julphar
Covington

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011665

« Back to Dashboard

NDA 011665 describes MESTINON, which is a drug marketed by Valeant Pharm Intl, Valeant Pharms, and Valeant Pharms Llc, and is included in four NDAs. It is available from two suppliers. Additional details are available on the MESTINON profile page.

The generic ingredient in MESTINON is pyridostigmine bromide. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.

Summary for 011665

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 011665

Mechanism of ActionCholinesterase Inhibitors

Medical Subject Heading (MeSH) Categories for 011665

Suppliers and Packaging for NDA: 011665

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MESTINON pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 011665 NDA Valeant Pharmaceuticals North America LLC 0187-3013 0187-3013-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30)
MESTINON pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 011665 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-301 68682-301-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-301-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength180MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Moodys
Fuji
McKesson
Teva
Queensland Health
Cipla
Colorcon
Fish and Richardson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot